Table 1.
Overall Patient Demographics and Clinicopathologic Features
| Total cases (N=132) | ||
|---|---|---|
| Age (years) | 60 (19–85) | |
| Sex | Female | 60 (45.4%) |
| Male | 72 (55.5%) | |
| T stage | 1 | 6 (4.5%) |
| 2 | 15 (11.4%) | |
| 3 | 67 (50.8%) | |
| 4 | 39 (29.5%) | |
| n/a | 5 (3.8%) | |
| Lymph node metastasis | Absent | 22 (16.7%) |
| Present | 106 (80.3%) | |
| n/a | 4 (3.0%) | |
| Mesenteric tumor deposit | Absent | 41 (31.1%) |
| Present | 86 (65.1%) | |
| n/a | 5 (3.8%) | |
| Liver metastasis | Absent | 55 (41.7%) |
| Present | 77 (58.3%) | |
| WHO grade | Grade 1 | 86 (65.1%) |
| Grade 2 | 22 (16.7%) | |
| n/a | 24 (18.2%) | |
| Follow up (months) | 48 (1–190) | |
| Survival status | Alive | 96 (72.7%) |
| Died of disease | 25 (19.0%) | |
| Died of other causes | 11 (8.3% | |